Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification

Abstract Background 5-Aminolevulinic acid (ALA) recently received much attention due to its potential application in many fields. In this study, an ALA production strain of Escherichia coli was constructed by rational metabolic engineering and stepwise improvement based on known regulatory and metab...

Full description

Bibliographic Details
Main Authors: Changchuan Ye, Yuting Yang, Xi Chen, Lijie Yang, Xia Hua, Mengjie Yang, Xiangfang Zeng, Shiyan Qiao
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Journal of Biological Engineering
Subjects:
Online Access:https://doi.org/10.1186/s13036-022-00307-7
_version_ 1798030008193646592
author Changchuan Ye
Yuting Yang
Xi Chen
Lijie Yang
Xia Hua
Mengjie Yang
Xiangfang Zeng
Shiyan Qiao
author_facet Changchuan Ye
Yuting Yang
Xi Chen
Lijie Yang
Xia Hua
Mengjie Yang
Xiangfang Zeng
Shiyan Qiao
author_sort Changchuan Ye
collection DOAJ
description Abstract Background 5-Aminolevulinic acid (ALA) recently received much attention due to its potential application in many fields. In this study, an ALA production strain of Escherichia coli was constructed by rational metabolic engineering and stepwise improvement based on known regulatory and metabolic information and CRISPR/Cas9 mediated gene knockout. Results A metabolic strategy to produce ALA directly from glucose in this recombinant E. coli via the C5 pathway was applied herein. The rational metabolic engineering by gene knockouts significantly improved ALA production from 662.3 to 1601.7 mg/L. In addition, we managed to synergistically produce ALA via the C4 pathway in recombinant strain. The expression of a modified hemA gene, encoding an ALA synthase from Rhodobacter sphaeroides, improved ALA production from 1601.7 to 2099.7 mg/L. After 24 h cultivation, a yield of 0.210 g ALA per g glucose was achieved by constructed E. coli D5:FYABD-RSA. Conclusion Our study revealed that an industrially competitive strain can be efficiently developed by metabolic engineering based on combined rational modification and optimization of gene expression.
first_indexed 2024-04-11T19:34:29Z
format Article
id doaj.art-bd55f3d2d7ce455abbd23af8c0da8aae
institution Directory Open Access Journal
issn 1754-1611
language English
last_indexed 2024-04-11T19:34:29Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Journal of Biological Engineering
spelling doaj.art-bd55f3d2d7ce455abbd23af8c0da8aae2022-12-22T04:06:55ZengBMCJournal of Biological Engineering1754-16112022-10-0116111510.1186/s13036-022-00307-7Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modificationChangchuan Ye0Yuting Yang1Xi Chen2Lijie Yang3Xia Hua4Mengjie Yang5Xiangfang Zeng6Shiyan Qiao7State Key Laboratory of Animal Nutrition, Ministry of Agriculture Feed Industry Centre, China Agricultural UniversityState Key Laboratory of Animal Nutrition, Ministry of Agriculture Feed Industry Centre, China Agricultural UniversityState Key Laboratory for Agro-Biotechnology, and Ministry of Agriculture and Rural Affairs, Key Laboratory for Pest Monitoring and Green Management, Department of Plant Pathology, China Agricultural UniversityState Key Laboratory of Animal Nutrition, Ministry of Agriculture Feed Industry Centre, China Agricultural UniversityState Key Laboratory for Agro-Biotechnology, and Ministry of Agriculture and Rural Affairs, Key Laboratory for Pest Monitoring and Green Management, Department of Plant Pathology, China Agricultural UniversityNational Feed Engineering Technology Research CentreState Key Laboratory of Animal Nutrition, Ministry of Agriculture Feed Industry Centre, China Agricultural UniversityState Key Laboratory of Animal Nutrition, Ministry of Agriculture Feed Industry Centre, China Agricultural UniversityAbstract Background 5-Aminolevulinic acid (ALA) recently received much attention due to its potential application in many fields. In this study, an ALA production strain of Escherichia coli was constructed by rational metabolic engineering and stepwise improvement based on known regulatory and metabolic information and CRISPR/Cas9 mediated gene knockout. Results A metabolic strategy to produce ALA directly from glucose in this recombinant E. coli via the C5 pathway was applied herein. The rational metabolic engineering by gene knockouts significantly improved ALA production from 662.3 to 1601.7 mg/L. In addition, we managed to synergistically produce ALA via the C4 pathway in recombinant strain. The expression of a modified hemA gene, encoding an ALA synthase from Rhodobacter sphaeroides, improved ALA production from 1601.7 to 2099.7 mg/L. After 24 h cultivation, a yield of 0.210 g ALA per g glucose was achieved by constructed E. coli D5:FYABD-RSA. Conclusion Our study revealed that an industrially competitive strain can be efficiently developed by metabolic engineering based on combined rational modification and optimization of gene expression.https://doi.org/10.1186/s13036-022-00307-7E. coli5-Aminolevulinic AcidCRISPR/cas9T7 Expression SystemMetabolic engineering
spellingShingle Changchuan Ye
Yuting Yang
Xi Chen
Lijie Yang
Xia Hua
Mengjie Yang
Xiangfang Zeng
Shiyan Qiao
Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification
Journal of Biological Engineering
E. coli
5-Aminolevulinic Acid
CRISPR/cas9
T7 Expression System
Metabolic engineering
title Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification
title_full Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification
title_fullStr Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification
title_full_unstemmed Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification
title_short Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification
title_sort metabolic engineering of escherichia coli bw25113 for the production of 5 aminolevulinic acid based on crispr cas9 mediated gene knockout and metabolic pathway modification
topic E. coli
5-Aminolevulinic Acid
CRISPR/cas9
T7 Expression System
Metabolic engineering
url https://doi.org/10.1186/s13036-022-00307-7
work_keys_str_mv AT changchuanye metabolicengineeringofescherichiacolibw25113fortheproductionof5aminolevulinicacidbasedoncrisprcas9mediatedgeneknockoutandmetabolicpathwaymodification
AT yutingyang metabolicengineeringofescherichiacolibw25113fortheproductionof5aminolevulinicacidbasedoncrisprcas9mediatedgeneknockoutandmetabolicpathwaymodification
AT xichen metabolicengineeringofescherichiacolibw25113fortheproductionof5aminolevulinicacidbasedoncrisprcas9mediatedgeneknockoutandmetabolicpathwaymodification
AT lijieyang metabolicengineeringofescherichiacolibw25113fortheproductionof5aminolevulinicacidbasedoncrisprcas9mediatedgeneknockoutandmetabolicpathwaymodification
AT xiahua metabolicengineeringofescherichiacolibw25113fortheproductionof5aminolevulinicacidbasedoncrisprcas9mediatedgeneknockoutandmetabolicpathwaymodification
AT mengjieyang metabolicengineeringofescherichiacolibw25113fortheproductionof5aminolevulinicacidbasedoncrisprcas9mediatedgeneknockoutandmetabolicpathwaymodification
AT xiangfangzeng metabolicengineeringofescherichiacolibw25113fortheproductionof5aminolevulinicacidbasedoncrisprcas9mediatedgeneknockoutandmetabolicpathwaymodification
AT shiyanqiao metabolicengineeringofescherichiacolibw25113fortheproductionof5aminolevulinicacidbasedoncrisprcas9mediatedgeneknockoutandmetabolicpathwaymodification